2m 2m 2m 2m 2m 2m 2m
ROIVANT SCIENCES (ROIV)
NASDAQ
$35.87-$0.62 (-1.71%)
Price as of Oct 26, 2026 5:14 PM EDT- $26.0BMarket Cap
- 100.27%1-Year Change
- BiotechnologyIndustry
ROIVANT SCIENCES (ROIV)
$35.87-$0.62 (-1.71%)
ROIV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $36.49 | ||
Change | -$0.96 (-2.56%) | ||
Open | $37.18 | ||
High | $37.42 | ||
Low | $36.36 | ||
Previous Close | $37.45 | ||
Volume | 8,225,577 | ||
30-Day Average Volume | 6,572,461 | ||
1-Week Change | 8.83% | ||
1-Month Change | -0.90% | ||
1-Year Change | 100.27% | ||
3-Year Change | 324.55% | ||
5-Year Change | 436.62% | ||
Fundamentals | |||
Shares Outstanding | 713.5M | ||
Total Assets | $5.3B | ||
Market Cap | $26.0B | ||
Enterprise Value | $24.8B | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$189.8M | ||
Free Cash Flow | -$270.9M | ||
EBIT | -$193.8M | ||
EBITDA | -$193.2M | ||
Net Working Capital | $4.5B | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -128 | ||
Enterprise Value/Revenue | 17,191 | ||
P/B | 6 | ||
P/E | -140 | ||
PEG | 1 | ||
Price/Free Cash Flow | -96 | ||
Price/Operating Cash Flow | -96 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue